Bruker (BRKR) PT Raised to $29 at Jefferies Following Strong 4Q Results
Jefferies analyst Brandon Couillard reiterates Buy rating and raises price target on Bruker Corp. (NASDAQ: BRKR) to $29 (from $28) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
